The 6th workshop of CAPICE project on “Drug Development and Target Validation” took place at Janssen Pharmaceuticals campus Beerse, Belgium and was held from 7 to 9 October 2019. There were top-level lectures, ESRs get exposure to the industry at the headquarters of Janssen.
The concepts were covered by expert scientists from Janssen Pharmaceuticals during the workshop. The duration of the workshop is of 3 days. There was a visit to “Dr Paul Janssen Research Center (PJRC)” and “Introduction to JLabs” in the morning session of the first day. During the afternoon session of the first day, Dr. Amy Leval talked about “Industry career development intro”, followed by a lecture on “ Data harmonization and federated infrastructures for healthcare research” given by Dr. Michel Van Speybroek and "Drug Development Overview" talk given by Dr. Shane Kavanagh.
During the morning session of the second day, Dr. Marc Ceusters gave a lecture on “ Compound Development: Integration of Diverse Functional Areas”, followed lecture on “Experimental Medicine: Bridging Early and Late Development” given by Dr. Luc van Nueten and followed by "Translation of Animal Data into Clinical Plans" by Dr. Peter de Boer. During the afternoon session of the second day, there was a talk on "Imaging in Neuroscience Therapeutics Development" by Dr. Mark Schmidt, followed lecture on "Translating Ideas into Clinical Studies" by Dr. Maarten Timmers, then there was an interactive discussion on "Careers in Neuroscience".
During the third day, Dr. Sarah Bergen gave a lecture on “ Drug target validation in a genetics context”, followed lecture on “Drug target validation and machine learning” given by Dr. Felipe Golib and followed by "Industry career development" by Dr. Amy Leval. On average, it takes at least 16 years for a new medicine to complete the journey from initial discovery to the marketplace.
The average cost to research and develop each successful drug is estimated to be $2.6 billion.
